Overview

Gender

male

Prior to joining Autolus as Chief Medical Officer, Vijay Reddy Peddareddigari worked as Senior Director and Clinical Leader in early development at Janssen Oncology (Johnson & Johnson), specialising in early and mid-stage clinical development. Prior to this he was at GlaxoSmithKline, and spent over six years working and leading numerous programmes in different areas of oncology such as signal transduction, cancer epigenetics and immune oncology from pre-candidate selection stage up to late development. At GlaxoSmithKline, as the Lead Early Development Physician on the MEK inhibitor (Trametinib) programme, he was responsible for accelerating early development and rapid transition to late stage development, leading to subsequent approval for treatment of metastatic melanoma. Vijay obtained his MBBS from Sri Venkateshwara Medical College, Tirupati and MD in biochemistry and molecular biology from All India Institute of Medical Sciences, New Delhi. He completed a residency in internal medicine at Albert Einstein Medical Center and a Fellowship in medical oncology from MD Anderson Cancer Center.